Statement on Deviation or Variation of funds
SAIPARENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sai Parenterals Limited filed a no-deviation statement for its IPO proceeds. The IPO raised ₹2,850 million (approx. ₹285 crore) between March 24–27, 2026 (anchor date: March 23, 2026). The monitoring agency is India Ratings & Research Private Limited. Seven usage categories were reported — covering capacity expansion, R&D centre, debt repayment, working capital, subsidiary acquisition funding, general corporate purposes, and issue expenses — with ₹1,107.95 million already utilised under capacity expansion and zero deviation reported across all heads. Both the Audit Committee and auditors reviewed the statement and had no comments.
No deviations in IPO fund utilisation is a positive signal, confirming the company is on track with its stated deployment plan. This should be neutral to mildly positive for investor confidence, particularly given the recent nature of the IPO.